This study demonstrated that decreased TUSC3 expression is associated with higher TNM staging in pancreatic cancer and is an independent prognostic factor predictive of poor long-term outcome for resected pancreatic cancer patients. Here, TUSC3 is linked to familial pancreatic carcinoma.